» Articles » PMID: 33189939

Early Transmission of SARS-CoV-2 in South Africa: An Epidemiological and Phylogenetic Report

Abstract

Objectives: The Network for Genomic Surveillance in South Africa (NGS-SA) was formed to investigate the introduction and understand the early transmission dynamics of the SARS-CoV-2 epidemic in South-Africa.

Design: This paper presents the first results from this group, which is a molecular epidemiological study of the first 21 SARS-CoV-2 whole genomes sampled in the first port of entry - KwaZulu-Natal (KZN) - during the first month of the epidemic. By combining this with calculations of the effective reproduction number (R), it aimed to shed light on the patterns of infections in South Africa.

Results: Two of the largest provinces - Gauteng and KZN - had a slow growth rate for the number of detected cases, while the epidemic spread faster in the Western Cape and Eastern Cape. The estimates of transmission potential suggested a decrease towards R = 1 since the first cases and deaths, but a subsequent estimated R average of 1.39 between 6-18 May 2020. It was also demonstrated that early transmission in KZN was associated with multiple international introductions and dominated by lineages B1 and B. Evidence for locally acquired infections in a hospital in Durban within the first month of the epidemic was also provided.

Conclusion: The COVID-19 pandemic in South Africa was very heterogeneous in its spatial dimension, with many distinct introductions of SARS-CoV2 in KZN and evidence of nosocomial transmission, which inflated early mortality in KZN. The epidemic at the local level was still developing and NGS-SA aimed to clarify the dynamics in South Africa and devise the most effective measures as the outbreak evolved.

Citing Articles

Inclusive education pandemic: Learning barriers for children with disabilities in South Africa.

Chirowamhangu R Afr J Disabil. 2025; 13():1462.

PMID: 39822750 PMC: 11736512. DOI: 10.4102/ajod.v13i0.1462.


Genomic and epidemiological analysis of SARS-CoV-2 variants isolated in Guinea: a routine sequencing implementation.

Mbaye A, Diallo H, Gnimadi T, Kadio K, Soumah A, Koivogui J BMC Infect Dis. 2025; 25(1):3.

PMID: 39748303 PMC: 11696909. DOI: 10.1186/s12879-024-10411-2.


Spatiotemporal evolution and transmission dynamics of Alpha and Delta SARS-CoV-2 variants contributing to sequential outbreaks in Cambodia during 2021.

Su Y, Zeller M, Ou T, Ma J, Pum L, Zhang R Commun Med (Lond). 2024; 4(1):252.

PMID: 39604601 PMC: 11603031. DOI: 10.1038/s43856-024-00685-7.


Technological Barriers to Routine Genomic Surveillance for Vaccine Development Against SARS-CoV-2 in Africa: A Systematic Review.

Konono K, Msusa K, Mpinganjira S, Amani A, Nyagupe C, Ngigi M Influenza Other Respir Viruses. 2024; 18(11):e70047.

PMID: 39557412 PMC: 11573421. DOI: 10.1111/irv.70047.


An Oxford Nanopore Technology-Based Hepatitis B Virus Sequencing Protocol Suitable for Genomic Surveillance Within Clinical Diagnostic Settings.

Tshiabuila D, Choga W, San J, Maponga T, van Zyl G, Giandhari J Int J Mol Sci. 2024; 25(21).

PMID: 39519254 PMC: 11546910. DOI: 10.3390/ijms252111702.


References
1.
Li X, Zai J, Zhao Q, Nie Q, Li Y, Foley B . Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2. J Med Virol. 2020; 92(6):602-611. PMC: 7228310. DOI: 10.1002/jmv.25731. View

2.
Msomi N, Mlisana K, de Oliveira T . A genomics network established to respond rapidly to public health threats in South Africa. Lancet Microbe. 2020; 1(6):e229-e230. PMC: 7434425. DOI: 10.1016/S2666-5247(20)30116-6. View

3.
Sagulenko P, Puller V, Neher R . TreeTime: Maximum-likelihood phylodynamic analysis. Virus Evol. 2018; 4(1):vex042. PMC: 5758920. DOI: 10.1093/ve/vex042. View

4.
Sohrabi C, Alsafi Z, ONeill N, Khan M, Kerwan A, Al-Jabir A . World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020; 76:71-76. PMC: 7105032. DOI: 10.1016/j.ijsu.2020.02.034. View

5.
Nishiura H, Linton N, Akhmetzhanov A . Serial interval of novel coronavirus (COVID-19) infections. Int J Infect Dis. 2020; 93:284-286. PMC: 7128842. DOI: 10.1016/j.ijid.2020.02.060. View